Share Buyback

PROCEPT BioRobotics reports record Aquablation procedures but lowers 2026 revenue guidance, signaling a strategic shift for long-term profitability.

Asbury Automotive nets $210M from strategic dealership sales, funneling capital into debt reduction and a massively expanded share repurchase program.

The Kentucky Derby operator posts record revenue and operational earnings, yet a 28% drop in quarterly net income reveals a complex story of growth and challenges.

The secure identity firm beat Wall Street estimates with accelerating revenue and record cash flow, signaling major growth and increased shareholder returns.

The certification giant posts 6.5% organic growth, rewarding investors while doubling down on sustainability, renewables, and cybersecurity acquisitions.

The professional information giant posted robust 2025 earnings while ramping up AI investment and navigating a pivotal CEO transition. Here's what it means.

Posting sector-leading 6.5% organic growth, the testing and certification giant validates its LEAP | 28 strategy with strong profits and a new buyback.

With a 61% profit surge, the Dutch tank storage giant rewards investors while launching a €4B plan to dominate both traditional and green energy infrastructure.

After a record 2025 with $51.1M in revenue, the seismic data firm rewards investors, proving its resilience in a volatile Canadian energy market.

Heritage Insurance projects a stunning full-year return on equity over 45%, setting the stage for a blockbuster earnings report on March 9.

Archrock crushes profit estimates and hikes its dividend, signaling strong confidence as it positions to power the soaring energy demands of LNG and AI.

Logistics giant faces falling profits from weak ocean freight, but a diversification strategy and a massive new share buyback signal long-term confidence.

With pivotal data imminent for its blockbuster hopeful AXPAXLI, Ocular Therapeutix faces a critical month of investor meetings amid commercial headwinds.

Life Time posts record 2025 earnings and a 230% Q4 profit surge, announcing a $500M share buyback and an aggressive expansion of its 'athletic country clubs'.

As ING's massive share repurchase program crosses the two-thirds mark, analysts weigh shareholder rewards against the bank's long-term growth strategies.

Beam Therapeutics is set to announce its 2025 financial results and a new liver-targeted therapy, a key moment for its base editing platform and investors.

With strong growth in key sectors but weakness in others, Plexus management faces a pivotal moment at the upcoming Raymond James investor conference.

Amid financial headwinds, CISO Global appoints a new EVP to accelerate AI innovation, enhance operational efficiency, and gain a competitive edge.

Anavex Life Sciences adds AMEOS Group CEO Dr. Axel Paeger to its board, a strategic move signaling a push into European markets for its CNS therapies.

The pizza giant posts robust sales and expands market share, crediting its 'Hungry for MORE' strategy and rewarding investors with a major dividend boost.